Veris Health Cancer Care Platform for Underserved Patients
This study is looking at how well the Veris Health Cancer Care Platform works for cancer patients who may have challenges accessing healthcare, such as language barriers or limited technology. The Veris Health platform uses at-home devices to monitor your health, including temperature, heart rate, and blood pressure, and sends this information to your cancer care team. The goal is to make sure this system is easy to use and helpful for all patients, especially those who are underserved. Researchers want to understand how usable and acceptable the platform is, and what patients need and prefer. To join, you must be an adult (18+) with a cancer diagnosis, be receiving or starting cancer treatment, and be able to use a mobile app and home devices. You should also have at least one barrier to healthcare access, such as Spanish as your primary language, being uninsured, or having Medicaid. This study is currently observing participants and aims to enroll 50 people.
- Study design
- This is an observational study, meaning researchers will watch how people use the Veris Health Cancer Care Platform. It plans to include 50 participants.
- What's involved
- You would use and interact with a mobile application and in-home devices for physiological monitoring. The study will assess usability, design, and user needs over 5 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will assess outcomes like usability and user needs at 5 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Bridging the Gap: Enhancing Cancer Care for Underserved Populations With the Veris Health Cancer Care Platform
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Usability of the Veris Health Cancer Care Platform5 Months
Usability of the Veris Health Cancer Care platform as assessed by the Software Usability Measurement Inventory (SUMI) among patients, caretakers, and healthcare teams. Measure: SUMI total and domain scores Time Frame: During study participation
- Product Design Usability and Acceptability5 Months
Ease of use, accessibility, and acceptability of the Veris Health Cancer Care platform based on A/B testing of product design features. Measure: Comparative usability metrics (e.g., task completion success, user preference) Time Frame: During study participation
- User Needs and Preferences5 Months
User-identified needs, preferences, and barriers to use of the Veris Health Cancer Care platform. Measure: Qualitative themes derived from user interviews and focus groups Time Frame: During study participation